{"text_format":"3","workbook":"xls","n_sheets":6,"sheets":[" Instructions - Please Read","Budget","Personnel","Milestone Payments","QIMR Berghofer","Sheet1"],"not_rendered":{"external_links":1,"defined_names":29},"read":"whole","date_system":"1904","formulas":"cached_only"}

{"sheet":" Instructions - Please Read","index":0,"n_rows":20,"n_cols":1,"rows_kept":20,"flags":["formulas_cached_only"]}
["Instructions for Completing Amgen Investigator Sponsored Study Budget Request Form"]
[]
["1. All information is to be provided in English."]
["2. All costs are to be provided exclusive of any taxes (VAT, GST etc.)"]
["3. All costs are to be included as full cost - if Amgen is contributing a percentage of total study cost this is to be entered in the appropriate field"]
["4. Please do not add columns or rows - if additional rows are needed, unhide rows as directed or contact your Amgen representative"]
["5. Please do not change any formulas within the worksheet - if changes are needed please contact your Amgen representative to discuss"]
["6. Include nature of frequency (e.g. annual, monthly, per Site) and/or details on deliverables in additional information column"]
["7. If further information relating to a line item is available please include in comment column"]
["8. For consumable/pass-through items please provide supporting documentation (e.g. quotation from supplier, supplier price list etc.)"]
[]
["Non-Subject Related Fees"]
["1. All costs are to be included as procedure/process cost and number of occurrences, hourly rate to perform activity and number of hours to perform, or FTE rate and % of FTE allocated to activity"]
[]
["Subject Related Fees"]
["1. Include allocations on a per subject basis"]
["2. Items which are not to be performed on all subjects (e.g. screen fails, additional procedures etc.) can be included in Additional Subject Items section"]
[]
[]
["Þ Not all sections should be completed. Depending of the kind of study, you may need or not need to complete all of the sections in the budget sheet. Please only complete fees in the sections applicable for your study."]

{"sheet":"Budget","index":1,"n_rows":96,"n_cols":9,"rows_kept":96,"merged":[[1,1,1,10],[2,1,2,10],[3,1,3,10],[4,3,4,10],[15,0,15,6],[16,8,16,13],[17,8,17,13],[18,8,18,13],[19,8,19,13],[20,8,20,13],[24,8,24,13],[25,8,25,13],[26,8,26,13],[27,8,27,13],[28,8,28,13],[29,8,29,13],[30,8,30,13],[31,8,31,13],[32,8,32,13],[33,8,33,13],[34,8,34,13],[36,8,36,13],[37,8,37,13],[38,0,38,3],[38,8,38,13],[40,0,40,6],[43,8,43,13],[49,8,49,13],[50,8,50,13],[51,8,51,13],[52,8,52,13],[53,8,53,13],[60,8,60,13],[61,8,61,13],[62,8,62,13],[63,8,63,13],[64,8,64,13],[65,8,65,13],[66,8,66,13],[67,8,67,13],[68,8,68,13],[69,8,69,13],[70,8,70,13],[71,8,71,13],[72,8,72,13],[73,8,73,13],[74,8,74,13],[75,8,75,13],[76,8,76,13],[77,8,77,13],[78,8,78,13],[79,8,79,13],[80,8,80,13],[81,8,81,13],[82,8,82,13],[83,8,83,13],[84,8,84,13],[89,0,89,2],[95,0,95,10],[97,0,97,10]],"flags":["formulas_cached_only"]}
["Protocol Number:",20177440]
["Institution Name: \n(or site number for multi site studies)"]
["PI Name (First, Last Name): ","A/Prof Brett Hughes"]
["Study Title: ","Pre-surgical evaluation of anti-PD1 with Denosumab in patients with operable stage I-IIIA NSCLC"]
["Participating Countries:","Australia","Other Countries:","None"]
["Currency:","AUD"]
["Therapeutic Area:"]
["Amgen Product:"]
["Phase:","II"]
["Length of Study (From Screening to End of Study Visit (months/years):","3 months"]
["Overhead (Indirect) Cost Rate %:",{"v":0.2,"d":"20.0%"}]
["Estimated Number of Enrolled Subjects:  ",30]
["Number of Site(s) Participating",4]
["What percentage of the total study costs would be coming from Amgen:  ",null,{"v":1,"d":"100.0%"}]
[]
["Non-Subject Related Fees"]
["Description of Services","Additional Information","Unit Cost/\nHourly Rate\n(exclusive of overhead)","Frequency of occurrence/\n# of hours ","Overhead Applicable","Amgen %","Total Amount Payable","Total Amount Payable\n(including overhead)","Comments"]
["HREC  Application","Multisite application",{"v":5000,"d":"5,000.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":5000,"d":"5,000.00"},{"v":5000,"d":"5,000.00"}]
["CTN","Application",{"v":350,"d":"350.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":350,"d":"350.00"},{"v":350,"d":"350.00"}]
["QIMR Fees","RA, samples etc.",{"v":275343,"d":"275,343.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":275343,"d":"275,343.00"},{"v":275343,"d":"275,343.00"}]
["Electronic Database","Software purchase & Annual fee for 3 years",{"v":18000,"d":"18,000.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":18000,"d":"18,000.00"},{"v":18000,"d":"18,000.00"}]
["eCRF set up","Development  CRFs and data collection tools",{"v":150,"d":"150.00"},{"v":35,"d":"35.0"},"No",{"v":1,"d":"100.0%"},{"v":5250,"d":"5,250.00"},{"v":5250,"d":"5,250.00"}]
["Setup fee for lead site ","RBWH ",{"v":8000,"d":"8,000.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":8000,"d":"8,000.00"},{"v":8000,"d":"8,000.00"}]
["RGO Fees ","MNHHS, MSHHS and Mater",{"v":5100,"d":"5,100.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":5100,"d":"5,100.00"},{"v":5100,"d":"5,100.00"}]
["Setup fee each accepting site","TPCH, Mater, PAH includes governance review",{"v":2000,"d":"2,000.00"},{"v":3,"d":"3.0"},"No",{"v":1,"d":"100.0%"},{"v":6000,"d":"6,000.00"},{"v":6000,"d":"6,000.00"}]
["Site administration Fee","Yr 2 Fee - RBWH paid qtrly",{"v":1000,"d":"1,000.00"},{"v":4,"d":"4.0"},"No",{"v":1,"d":"100.0%"},{"v":4000,"d":"4,000.00"},{"v":4000,"d":"4,000.00"}]
["Site administration Fee","Yr 2 Fee - TPCH, Mater, PAH paid qrtly",{"v":500,"d":"500.00"},{"v":12,"d":"12.0"},"No",{"v":1,"d":"100.0%"},{"v":6000,"d":"6,000.00"},{"v":6000,"d":"6,000.00"}]
["Close out Fee","Per site",{"v":500,"d":"500.00"},{"v":4,"d":"4.0"},"No",{"v":1,"d":"100.0%"},{"v":2000,"d":"2,000.00"},{"v":2000,"d":"2,000.00"}]
["Archiving","Per site",{"v":1500,"d":"1,500.00"},{"v":4,"d":"4.0"},"No",{"v":1,"d":"100.0%"},{"v":6000,"d":"6,000.00"},{"v":6000,"d":"6,000.00"}]
["Publications","2-3 papers",{"v":10000,"d":"10,000.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":10000,"d":"10,000.00"},{"v":10000,"d":"10,000.00"}]
["Pharmacy setup fees","TPCH, Mater, PAH",{"v":1550,"d":"1,550.00"},{"v":3,"d":"3.0"},"No",{"v":1,"d":"100.0%"},{"v":4650,"d":"4,650.00"},{"v":4650,"d":"4,650.00"}]
["RBWH Pharmacy setup fees","RBWH Lead Pharmacy setup fees",{"v":2000,"d":"2,000.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":2000,"d":"2,000.00"},{"v":2000,"d":"2,000.00"}]
["Pharmacy Administration Fee","Yr 2 Fee - RBWH paid qtrly",{"v":500,"d":"500.00"},{"v":4,"d":"4.0"},"No",{"v":1,"d":"100.0%"},{"v":2000,"d":"2,000.00"},{"v":2000,"d":"2,000.00"}]
["Pharmacy Administration Fee","Yr 2 Fee - TPCH, Mater, PAH paid qtrly",{"v":337.5,"d":"337.50"},{"v":12,"d":"12.0"},"No",{"v":1,"d":"100.0%"},{"v":4050,"d":"4,050.00"},{"v":4050,"d":"4,050.00"}]
["Pharmacy Storage Fee","Storage fees refrigerated per annum",{"v":750,"d":"750.00"},{"v":8,"d":"8.0"},"No",{"v":1,"d":"100.0%"},{"v":6000,"d":"6,000.00"},{"v":6000,"d":"6,000.00"}]
["Pharmacy  (World Courier Refrigerated Shipper)","Courier Study Drug to Sites ( Nivolumab)",{"v":400,"d":"400.00"},{"v":9,"d":"9.0"},"No",{"v":1,"d":"100.0%"},{"v":3600,"d":"3,600.00"},{"v":3600,"d":"3,600.00"}]
["Pathology Setup Fee for Lead Site","RBWH ",{"v":500,"d":"500.00"},{"v":1,"d":"1.0"},"No",{"v":1,"d":"100.0%"},{"v":500,"d":"500.00"},{"v":500,"d":"500.00"}]
["Pathology Setup fee for each accepting site","TPCH, Mater, PAH",{"v":200,"d":"200.00"},{"v":3,"d":"3.0"},"No",{"v":1,"d":"100.0%"},{"v":600,"d":"600.00"},{"v":600,"d":"600.00"}]
["Non-Subject Related Fee Total:",{"$nulls":5},{"v":374443,"d":"374,443.00"},{"v":374443,"d":"374,443.00"}]
[]
["Subject Related Fees "]
["Description of Services","Additional Information","Unit Cost/\nHourly Rate\n(exclusive of overhead)","Frequency of occurrence/\n# of hours\n(per subject)","Overhead Applicable","Amgen %","Total Amount Payable","Total Amount Payable\n(including overhead)"]
["A. Personnel - please include fees for an individual patient, not total number of subjects"]
["Per Patient","Study coordinator, data management",{"v":4530,"d":"4,530.00"},{"v":1,"d":"1.0"},"Yes",{"v":1,"d":"100%"},{"v":4530,"d":"4,530.00"},{"v":5436,"d":"5,436.00"}]
["Personnel Subtotal:",{"$nulls":5},{"v":4530,"d":"4,530.00"},{"v":5436,"d":"5,436.00"}]
["Total Subject-Related Fee: (Per subject cost x # of Subjects + Additional Subject Items)",{"$nulls":5},{"v":135900,"d":"135,900.00"},{"v":163080,"d":"163,080.00"}]
[]
[]
["B. Procedures* - please include fees for an individual patient, not total number of subjects"]
["Pharmacy dispensing","30 pts (2 dose) 60",{"v":200,"d":"200.00"},{"v":60,"d":"60.0"},"No",{"v":1,"d":"100%"},{"v":12000,"d":"12,000.00"},{"v":12000,"d":"12,000.00"}]
["Study Blood processing","7 timepoints per participant",{"v":50,"d":"50.00"},{"v":210,"d":"210.0"},"No",{"v":1,"d":"100%"},{"v":10500,"d":"10,500.00"},{"v":10500,"d":"10,500.00"}]
["Tumour block processing","Per participant is 3 blocks",{"v":100,"d":"100.00"},{"v":90,"d":"90.0"},"No",{"v":1,"d":"100%"},{"v":9000,"d":"9,000.00"},{"v":9000,"d":"9,000.00"}]
["Reimbursement of Nivolumab","30 pts (2 doses @240mg = 60 doses)",{"v":5176,"d":"5,176.00"},{"v":60,"d":"60.0"},"No",{"v":1,"d":"100%"},{"v":310560,"d":"310,560.00"},{"v":310560,"d":"310,560.00"}]
["Guided Tumour Biopsy","At relapse",{"v":900,"d":"900.00"},{"v":30,"d":"30.0"},"No",{"v":1,"d":"100%"},{"v":27000,"d":"27,000.00"},{"v":27000,"d":"27,000.00"}]
["Procedures Subtotal:",{"$nulls":5},{"v":369060,"d":"369,060.00"},{"v":369060,"d":"369,060.00"}]
[]
["C. Additional Subject Items"]
["Description of Services","Additional Information","Unit Cost/\nHourly Rate\n(exclusive of overhead)","Total Number of Occurrences","Overhead Applicable","Amgen %","Total Amount Payable","Total Amount Payable\n(including overhead)"]
["Example 1: Optional Scans","For rescreening",{"v":150,"d":"150.00"},{"v":10,"d":"10.0"},"Yes",{"v":1,"d":"100%"},{"v":1500,"d":"1,500.00"},{"v":1800,"d":"1,800.00"}]
["Example 2: Screen Failures",null,{"v":2000,"d":"2,000.00"},{"v":2,"d":"2.0"},"Yes",{"v":1,"d":"100%"},{"v":4000,"d":"4,000.00"},{"v":4800,"d":"4,800.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[{"$nulls":4},"No",{"v":1,"d":"100%"},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
["Additional Subject Items Subtotal:",{"$nulls":5},{"v":0,"d":"0.00"},{"v":0,"d":"0.00"}]
[]
[]
["Total Study Fees: (Total Subject-Related Fee + Total Non-Subject Related Fee)",{"$nulls":6},{"v":906583,"d":"906,583.00"}]
["Total Indirect Cost:"]
["Total Indirect Cost:"]
[]
[]
["* Clinical and Lab Procedures fees cover the cost of performing the listed procedure and the time it takes for the appropriate clinical personnel to perform it."]
[]
["Site agrees and warrants that it shall not seek reimbursement from any Subject or third party payor for any items or services that are funded by Company or provided without charge by Company for Study purposes. Site shall comply with Applicable Laws, regulations and payor guidance pertinent to the coverage of and reimbursement for items and services furnished in the context of the Study. "]

{"sheet":"Personnel","index":2,"n_rows":20,"n_cols":4,"rows_kept":20,"flags":["formulas_cached_only"]}
[]
[null,"Hours for Visit","Cost per Hour","Total Cost"]
["SCREEN",8,{"v":96.28188259109311,"d":"$96.28"},{"v":770.2550607287449,"d":"$770.26"}]
["W1D1",3,{"v":96.28188259109311,"d":"$96.28"},{"v":288.8456477732793,"d":"$288.85"}]
["W3D15",5,{"v":96.28188259109311,"d":"$96.28"},{"v":481.40941295546554,"d":"$481.41"}]
["SURGERY",4,{"v":96.28188259109311,"d":"$96.28"},{"v":385.12753036437243,"d":"$385.13"}]
["D28PS",4,{"v":96.28188259109311,"d":"$96.28"},{"v":385.12753036437243,"d":"$385.13"}]
["RELAPSE",3,{"v":96.28188259109311,"d":"$96.28"},{"v":288.8456477732793,"d":"$288.85"}]
["FU x 12",18,{"v":96.28188259109311,"d":"$96.28"},{"v":1733.073886639676,"d":"$1,733.07"}]
["DISCON",2,{"v":96.28188259109311,"d":"$96.28"},{"v":192.56376518218622,"d":"$192.56"}]
[]
["Total",47,null,{"v":4525.248481781376,"d":"$4,525.25"}]
[]
[]
[]
["As per CCS BSO:","Per Annum","Hourly rate"]
["NG6.4",{"v":176518,"d":"176,518"},{"v":89.33097165991903,"d":"$89.33"}]
["NG7.4",{"v":203988,"d":"203,988"},{"v":103.2327935222672,"d":"$103.23"}]
[]
["Average Rate",null,{"v":96.28188259109311,"d":"$96.28"}]

{"sheet":"Milestone Payments","index":3,"n_rows":16,"n_cols":5,"rows_kept":16,"merged":[[15,0,17,4]],"flags":["formulas_cached_only"]}
["MILESTONE ","Deliverable ","PAYMENT AMOUNT "]
["Initial Payment ","Upon execution of contract",{"v":90658.3,"d":"90,658.30"}]
["Second Payment","Upon receipt of competent authority (CA) and Ethics Committee (EC) approvals",{"v":181316.6,"d":"181,316.60"}]
["Upon enrollment of 5 patients","Upon enrollment of 5 out of 30  patients",{"v":67993.72499999999,"d":"67,993.73"}]
["Upon enrollment of 10 patients","Upon enrollment of 10 out of 30  patients",{"v":67993.72499999999,"d":"67,993.73"}]
["Upon enrollment of 15 patients","Upon enrollment of 15 out of 30  patients",{"v":67993.72499999999,"d":"67,993.73"}]
["Upon enrollment of 20 patients","Upon enrollment of 20 out of 30  patients",{"v":67993.72499999999,"d":"67,993.73"}]
["Upon enrollment of 25 patients","Upon enrollment of 25 out of 30  patients",{"v":67993.72499999999,"d":"67,993.73"}]
["Upon enrollment of 30 patients","Upon enrollment of 30 out of 30  patients",{"v":67993.72499999999,"d":"67,993.73"}]
["Upon completion of all patients visits","Upon completion of Last Subject Last Visit",{"v":90658.3,"d":"90,658.30"}]
["Final Payment","Upon receipt of final study documentation and report ",{"v":135987.44999999998,"d":"135,987.45"}]
[null,null,{"v":906582.9999999999,"d":"906,583.00"},"TOTAL ","AUD"]
[]
[]
[]
["*Please Note: Initial payment should be no more than 10% of the Total Study Fees, Second Payment should be around 20% of the Total Study Fees and Final payment should be no less than 15% of the Total Study Fees."]

{"sheet":"QIMR Berghofer","index":4,"n_rows":14,"n_cols":3,"rows_kept":14,"flags":["formulas_cached_only"]}
["Items","Amount (USD)","Amount (AUD)"]
["RA 1 year FTE",{"v":66244,"d":"$66,244.00"},{"v":86266.44094283109,"d":"$86,266.44"}]
["Nanostring chips",{"v":31957,"d":"$31,957.00"},{"v":41616.09584581326,"d":"$41,616.10"}]
["RNAseq",{"v":18000,"d":"$18,000.00"},{"v":23440.552155228546,"d":"$23,440.55"}]
["TCRseq",{"v":60000,"d":"$60,000.00"},{"v":78135.17385076181,"d":"$78,135.17"}]
["IHC consumables",{"v":35235,"d":"$35,235.00"},{"v":45884.900843859876,"d":"$45,884.90"}]
[]
["Total",{"v":211436,"d":"$211,436.00"},{"v":275343.16363849456,"d":"$275,343.16"}]
[]
[]
[]
[]
["Reagents and consumables based on commercial standard pricing"]
["\"RA\" = research assistant, RA6 research level, QIMR Berghofer Medical Research Institute (includes on-costs)"]

{"sheet":"Sheet1","index":5,"n_rows":58,"n_cols":8,"rows_kept":58,"hidden":true,"flags":["formulas_cached_only"]}
["Organizational TA","Duration","Overhead","Argentina",null,null,"Amgen Inc. - Clinical Billings"]
[{"$nulls":3},"Australia",null,null,"Accounts Payable","Accountspayablemailroom@amgen.com"]
["Bone","Weeks","Yes","Austria",null,null,"PO Box 667"]
["Cardiovascular","Months","No","Belgium",null,null,"Newbury Park, CA  91319"]
["Hematology/Oncology","Years",null,"Brazil"]
["Inflammation",null,null,"Bulgaria",null,null,"Amgen Australia Pty Limited"]
["Metabolic Disorders",null,null,"Canada",null,null,"Accounts Payable","clinical-payments-australia@amgen.com"]
["Nephrology",null,null,"Chile",null,null,"Mezzanine Level"]
["Neuroscience",null,null,"China",null,null,"115 Cotham Road"]
["Other",null,null,"Colombia",null,null,"Kew Victoria 3101"]
[{"$nulls":3},"Costa Rica"]
[{"$nulls":3},"Croatia",null,null,"Amgen Canada Inc."]
[{"$nulls":3},"Czech Republic",null,null,"Attn: Millie Hume","mhume@amgen.com  "]
[{"$nulls":3},"Denmark",null,null,"6775 Financial Drive, Suite 100"]
[{"$nulls":3},"Dominican Republic",null,null,"Mississauga, Ontario, L5N 0A4"]
[{"$nulls":3},"Estonia"]
[{"$nulls":3},"Finland"]
[{"$nulls":3},"France"]
[{"$nulls":3},"Germany"]
[{"$nulls":3},"Greece"]
[{"$nulls":3},"Guatemala"]
[{"$nulls":3},"Hong Kong"]
[{"$nulls":3},"Hungary"]
[{"$nulls":3},"Iceland"]
[{"$nulls":3},"India"]
[{"$nulls":3},"Ireland"]
[{"$nulls":3},"Israel"]
[{"$nulls":3},"Italy"]
[{"$nulls":3},"Japan"]
[{"$nulls":3},"Latvia"]
[{"$nulls":3},"Lebanon"]
[{"$nulls":3},"Lithuania"]
[{"$nulls":3},"Malaysia"]
[{"$nulls":3},"Mexico"]
[{"$nulls":3},"Netherlands"]
[{"$nulls":3},"New Zealand"]
[{"$nulls":3},"Norway"]
[{"$nulls":3},"Panama"]
[{"$nulls":3},"Peru"]
[{"$nulls":3},"Philippines"]
[{"$nulls":3},"Poland"]
[{"$nulls":3},"Portugal"]
[{"$nulls":3},"Romania"]
[{"$nulls":3},"Russia"]
[{"$nulls":3},"Serbia"]
[{"$nulls":3},"Singapore"]
[{"$nulls":3},"Slovakia"]
[{"$nulls":3},"Slovenia"]
[{"$nulls":3},"South Africa"]
[{"$nulls":3},"South Korea"]
[{"$nulls":3},"Spain"]
[{"$nulls":3},"Sweden"]
[{"$nulls":3},"Switzerland"]
[{"$nulls":3},"Taiwan"]
[{"$nulls":3},"Turkey"]
[{"$nulls":3},"United Kingdom"]
[{"$nulls":3},"Ukraine"]
[{"$nulls":3},"United States"]